Immune Tolerance in Mixed Chimeric Miniature Swine
混合嵌合小型猪的免疫耐受性
基本信息
- 批准号:6406133
- 负责人:
- 金额:$ 4.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-09-01 至
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by the applicant): Organ transplantation has become a
widespread treatment for many patients with end-stage renal, hepatic, cardiac,
and pulmonary disease. However, two major obstacles preventing greater
successes are donor organ availability and treatment related complications
including acute and chronic graft rejection. One attempt to avoid rejection is
via the creation of specific transplantation tolerance, defined as elimination
of the recipient?s immune response to a transplanted organ?s foreign antigens
while leaving other host responses intact. Tolerance represents a major goal of
modern transplant biology and is the focus of this research proposal.
Specifically, the Sachs laboratory has developed a large animal model of
tolerance using inbred miniature swine of known MHC haplotype. Using a
non-myelosuppressive preparation and a high dose peripheral blood stem cell
transplant protocol mixed lymphohematopoietic chimerism and transplant
tolerance can be induced in these animals. When mixed chimeric swine undergo
subsequent renal transplantation from the same donor of their stem cell
transplant they accept a kidney graft with no exogenous -immunosuppression.
This proposal will characterize the cellular nature of the immune tolerance
generated in these animals. Special focus will be on study of an observed
persistent sub-population of T-cells of donor origin in an effort to determine
their origin, identity, and functional activity. Research design includes
labeling of the donor inoculum prior to stem cell transplant to determine the
heredity of the persistent T-cell population as well as CML and MLR assays to
assess in vitro reactivity of these cells to the recipient. The importance of
this population will be further assessed by transferring them to a matched
naive animal to determine whether they will survive in this new host and
perhaps create tolerance in that animal. Understanding on a cellular and
molecular level the nature of this persistent donor T-cell population is
crucial to understanding the nature of the transplant tolerance created in
these remarkable animals.
描述(申请人提供):器官移植已成为
广泛治疗许多终末期肾、肝、心、心、肾、肝、心、肾、心、肾、肝、心、肾、肾、肝、心、肾、肝、心、
和肺部疾病。然而,两大障碍阻碍了更大的
成功的是供体器官的可获得性和治疗相关的并发症
包括急性和慢性移植物排斥反应。避免被拒绝的一种尝试是
通过创造特定的移植耐受,定义为消除
受体的?S对移植器官的免疫反应?S的异源抗原
同时保持其他主机响应不变。宽容代表着
现代移植生物学,也是本研究提案的重点。
具体地说,萨克斯实验室已经开发出一种大型动物模型
使用已知MHC单倍型的近交系小型猪的耐受性。使用
非骨髓抑制制剂和大剂量外周血干细胞
移植方案混合淋巴造血嵌合体和移植
可以在这些动物身上诱导耐受性。当混合嵌合体猪经历
来自同一干细胞供者的后续肾移植
移植他们接受没有外源性免疫抑制的肾移植。
这一建议将描述免疫耐受的细胞性。
在这些动物身上产生。将特别关注对观察到的
捐献者来源的T细胞的持久亚群,以努力确定
它们的起源、身份和功能活动。研究设计包括
干细胞移植前对供者接种的标记以确定
持续性T细胞群体的遗传性以及CML和MLR分析
评估这些细胞对受体的体外反应性。重要的是
将通过将他们转移到匹配的
幼稚的动物来决定它们是否能在这个新的宿主和
也许会让那只动物产生耐受性。对手机和手机的理解
在分子水平上,这种持久捐赠者T细胞群体的性质是
对理解移植耐受性的本质至关重要
这些非凡的动物。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Stem cell mobilization is life saving in an animal model of acute liver failure.
干细胞动员是在急性肝衰竭的动物模型中挽救生命。
- DOI:10.1097/sla.0b013e3181f4e479
- 发表时间:2010-10
- 期刊:
- 影响因子:9
- 作者:Mark AL;Sun Z;Warren DS;Lonze BE;Knabel MK;Melville Williams GM;Locke JE;Montgomery RA;Cameron AM
- 通讯作者:Cameron AM
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANDREW M. CAMERON其他文献
ANDREW M. CAMERON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANDREW M. CAMERON', 18)}}的其他基金
Development of an Interactive Bioethics Training Module for Healthcare Providers Treating Patients Who Need Liver Transplant for Alcohol-associated Liver Disease
为治疗酒精相关性肝病需要肝移植的患者的医疗保健提供者开发交互式生物伦理学培训模块
- 批准号:
10785093 - 财政年份:2023
- 资助金额:
$ 4.2万 - 项目类别:
Multidisciplinary approach to study of patients with Severe Alcoholic Hepatitis Undergoing Liver Transplantation
多学科方法对接受肝移植的重症酒精性肝炎患者进行研究
- 批准号:
10560540 - 财政年份:2019
- 资助金额:
$ 4.2万 - 项目类别:
Project 1-Cohort and Ethical Analysis of Patients undergoing Early Liver Transplant for Severe Alcoholic Hepatitis
项目1-严重酒精性肝炎早期肝移植患者的队列和伦理分析
- 批准号:
10356013 - 财政年份:2019
- 资助金额:
$ 4.2万 - 项目类别:
Project 1-Cohort and Ethical Analysis of Patients undergoing Early Liver Transplant for Severe Alcoholic Hepatitis
项目1-严重酒精性肝炎早期肝移植患者的队列和伦理分析
- 批准号:
10560558 - 财政年份:2019
- 资助金额:
$ 4.2万 - 项目类别:
Multidisciplinary approach to study of patients with Severe Alcoholic Hepatitis Undergoing Liver Transplantation
多学科方法对接受肝移植的重症酒精性肝炎患者进行研究
- 批准号:
10356010 - 财政年份:2019
- 资助金额:
$ 4.2万 - 项目类别:
Multidisciplinary approach to study of patients with Severe Alcoholic Hepatitis Undergoing Liver Transplantation
多学科方法对接受肝移植的重症酒精性肝炎患者进行研究
- 批准号:
10093975 - 财政年份:2019
- 资助金额:
$ 4.2万 - 项目类别:
相似海外基金
Immunoregulation of cellular immunity and tissue homeostasis during Chagas' disease
恰加斯病期间细胞免疫和组织稳态的免疫调节
- 批准号:
10448950 - 财政年份:2022
- 资助金额:
$ 4.2万 - 项目类别:
Gingival vaccination strategy to induce both humoral and cellular immunity ideal for elderly vaccination
诱导体液和细胞免疫的牙龈疫苗接种策略非常适合老年人疫苗接种
- 批准号:
22K09932 - 财政年份:2022
- 资助金额:
$ 4.2万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
mRNA encoding of immune receptor-targeting antibodies for the augmentation of vaccine-elicited cellular immunity.
编码免疫受体靶向抗体的 mRNA,用于增强疫苗引发的细胞免疫。
- 批准号:
10508093 - 财政年份:2022
- 资助金额:
$ 4.2万 - 项目类别:
From mtDNA stress to cellular immunity: Triggers, Mechanisms and Effectors
从线粒体DNA应激到细胞免疫:触发因素、机制和效应器
- 批准号:
10501418 - 财政年份:2022
- 资助金额:
$ 4.2万 - 项目类别:
From mtDNA stress to cellular immunity: Triggers, Mechanisms and Effectors
从线粒体DNA应激到细胞免疫:触发因素、机制和效应器
- 批准号:
10650823 - 财政年份:2022
- 资助金额:
$ 4.2万 - 项目类别:
Longitudinal SARS-CoV-2 mRNA vaccine-induced mucosal, serological, and cellular immunity in children and human milk
纵向 SARS-CoV-2 mRNA 疫苗诱导儿童和母乳中的粘膜、血清学和细胞免疫
- 批准号:
10568736 - 财政年份:2022
- 资助金额:
$ 4.2万 - 项目类别:
SHINING A LIGHT ON BAT CELLULAR IMMUNITY FOLLOWING VIRUS INFECTION
揭示病毒感染后蝙蝠细胞免疫
- 批准号:
10449406 - 财政年份:2022
- 资助金额:
$ 4.2万 - 项目类别:
From mtDNA stress to cellular immunity: Triggers, Mechanisms and Effectors
从线粒体DNA应激到细胞免疫:触发因素、机制和效应器
- 批准号:
10797812 - 财政年份:2022
- 资助金额:
$ 4.2万 - 项目类别:
Longitudinal SARS-CoV-2 mRNA vaccine-induced mucosal, serological, and cellular immunity in children and human milk
纵向 SARS-CoV-2 mRNA 疫苗诱导儿童和母乳中的粘膜、血清学和细胞免疫
- 批准号:
10895221 - 财政年份:2022
- 资助金额:
$ 4.2万 - 项目类别:
mRNA encoding of immune receptor-targeting antibodies for the augmentation of vaccine-elicited cellular immunity.
编码免疫受体靶向抗体的 mRNA,用于增强疫苗引发的细胞免疫。
- 批准号:
10662571 - 财政年份:2022
- 资助金额:
$ 4.2万 - 项目类别: